Toolkit/noncoding RNA manipulation

noncoding RNA manipulation

Engineering Method·Research·Since 2018

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Noncoding RNA manipulation is identified in a 2018 review as a CRISPR/Cas9-based epigenetic technique. The supplied evidence establishes only that it falls within the review’s scope and that CRISPR/Cas9 opened new routes into epigenetics.

Usefulness & Problems

Why this is useful

The available evidence supports a general role for CRISPR/Cas9 in enabling new approaches in epigenetics, with noncoding RNA manipulation listed as one such approach. No specific use case, assay context, or performance outcome for noncoding RNA manipulation is provided in the supplied material.

Problem solved

Based on the supplied review statements, this category addresses epigenetic investigation or intervention using CRISPR/Cas9. The specific scientific problem solved by noncoding RNA manipulation is not described in the provided evidence.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete method used to build, optimize, or evolve an engineered system.

Mechanisms

No mechanism tags yet.

Target processes

editingrecombinationselection

Implementation Constraints

The only implementation detail supported by the evidence is that this approach is framed as utilizing the CRISPR/Cas9 system. No construct architecture, Cas9 variant, guide RNA design, delivery method, or expression system is described.

The evidence is limited to review-level scope statements and does not define the molecular implementation, target noncoding RNA classes, or experimental results. No information is provided on efficiency, specificity, organismal context, or reproducibility.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1field impactsupports2018Source 1needs review

The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.

In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
Claim 2review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 3review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 4review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 5review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 6review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 7review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Claim 8review scopesupports2018Source 1needs review

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

Approval Evidence

1 source1 linked approval claimfirst-pass slug noncoding-rna-manipulation
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including ... noncoding RNA manipulation...

Source:

review scopesupports

The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

Source:

Comparisons

Source-backed strengths

A stated strength is its inclusion among novel epigenetic techniques enabled by the CRISPR/Cas9 system. No direct validation data, molecular targets, or comparative advantages for noncoding RNA manipulation are reported in the supplied evidence.

Ranked Citations

  1. 1.
    StructuralSource 1Stem Cells International2018Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl1. Extracted from this source document.